01—Abstract
Summary
Summary of the 10-Q filed October 24, 2024. Cited figures are marked; the original filing is the authoritative source.
Philip Morris International Inc. (PM) reported strong financial performance for the nine months ended September 30, 2024.
Net revenues increased by 7.8% to $28.2 billiona, and diluted EPS grew by 35.5% to $4.89, driven by favorable pricing across combustible tobacco and growth in smoke-free products, particularly ZYN nicotine pouches and IQOS heated tobacco products. The company's strategic shift towards a smoke-free future continues to gain momentum, with smoke-free product revenues up 16.1% year-over-year. Despite currency headwinds and ongoing investments in its smoke-free portfolio, PMI demonstrated robust operational improvements.
However, the company did record an impairment charge of $198 millionb related to the expected sale of its Vectura Group business and a $45 million charge for an Egypt sales tax assessment. Management provided an updated full-year outlook, expecting net cash provided by operating activities of approximately $11 billion, reflecting confidence in continued growth and profitability.
02—Key points
Key Highlights
- Net revenues increased by 7.8% to $28.2 billion for the nine months ended September 30, 2024, compared to the prior year.
- Diluted EPS rose significantly by 35.5% to $4.89 for the nine months ended September 30, 2024.
- Smoke-free product revenues saw a substantial increase of 16.1% for the nine months ended September 30, 2024.
- The Americas region showed particularly strong revenue growth of 19.8%, largely driven by ZYN nicotine pouches in the U.S.
- The company recorded an impairment charge of $198 million related to the planned sale of its Vectura Group business.
- An Egypt sales tax charge of $45 million was recorded, impacting the SSEA, CIS & MEA segment.
- PMI anticipates full-year net cash provided by operating activities to be around $11 billion.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2024, Philip Morris International Inc. kept $0.31.
- Revenue$9.91B100.0%
- Cost of revenue−$3.37B34.0%
- Gross profit$6.54B66.0%
- Operating costs−$2.89B29.2%
- Operating income$3.65B36.9%
- Interest, other & tax−$572.0M5.8%
- Net income$3.08B31.1%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2024filed October 24, 2024Financial Statements
Q3 FY2024 against Q3 FY2023
| Line item | Q3 FY2024Q3 FY2023 | Change |
|---|---|---|
| Revenue | $9.91B$9.14B | +8.4% |
| Cost of Revenue | $3.37B$3.17B | +6.4% |
| Gross Profit | $6.54B$5.98B | +9.5% |
| Operating Income | $3.65B$3.37B | +8.4% |
| Net Income | $3.08B$2.05B | +50.0% |
| EPS (Basic) | $1.98$1.32 | +50.0% |
| EPS (Diluted) | $1.97$1.32 | +49.2% |
| Shares Outstanding (Basic) | 1.55B1.55B | +0.2% |
| Shares Outstanding (Diluted) | 1.56B1.55B | +0.1% |
05—Questions
Frequently Asked Questions
What was the primary driver of the increase in net revenues?
The increase in net revenues was primarily driven by favorable pricing, particularly in combustible tobacco, and strong volume/mix performance in smoke-free products, notably ZYN nicotine pouches in the Americas and IQOS heated tobacco units across various regions.
What impact did the sale of Vectura Group have on the financial results?
PMI recorded an impairment charge of $198 million in the third quarter of 2024 related to Vectura's classification as held for sale. The company expects to close the sale of Vectura Group by the end of 2024.
How did currency fluctuations affect the company's performance?
Unfavorable currency movements had a negative impact, particularly on net revenues, due to fluctuations in the Egyptian pound, Japanese yen, and Russian ruble. For the nine months ended September 30, 2024, this unfavorable currency impact on net revenues was approximately $841 million.
What is the outlook for smoke-free products?
Philip Morris International is strategically focused on growing its smoke-free portfolio. Smoke-free product revenues increased by 16.1% year-over-year for the nine months ended September 30, 2024, driven by strong performance in brands like ZYN and IQOS, indicating continued positive momentum in this strategic area.
06—Continue